Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The S267F variant of sodium taurocholate co-transporting polypeptide is strongly associated with resistance to chronic hepatitis B and high level of serum total bile acids. | Liver Res | 2022 | 39958196 | PubTator, text mining | PubMed |
| Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases. | J Food Drug Anal | 2022 | 39666289 | PubTator, text mining | PubMed |
| IMPACT OF GRAVES' DISEASE AND ANTITHYROID DRUG THERAPY ON BONE MINERAL DENSITY - PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL RELEVANCE. | Acta Clin Croat | 2022 | 37492357 | PubTator, text mining | PubMed |
| Diabetes and COVID-19, a link revealed. | Life Med | 2022 | 36820103 | PubTator, text mining | PubMed |
| Preclinical species gene expression database: Development and meta-analysis. | Front Genet | 2022 | 36733943 | PubTator, text mining | PubMed |
| Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing. | Pharmaceutics | 2022 | 36678658 | PubTator, text mining | PubMed |
| Many Ways to Communicate-Crosstalk between the HBV-Infected Cell and Its Environment. | Pathogens | 2022 | 36678377 | PubTator, text mining | PubMed |
| Treatment of Drug-Induced Liver Injury. | Biomedicines | 2022 | 36672522 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer. | J Hepatocell Carcinoma | 2022 | 36606115 | PubTator, text mining | PubMed |
| Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target. | Gut | 2022 | 36591611 | PubTator, text mining | PubMed |
| Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose. | Front Oncol | 2022 | 36591496 | PubTator, text mining | PubMed |
| Can G-quadruplex become a promising target in HBV therapy? | Front Immunol | 2022 | 36591216 | PubTator, text mining | PubMed |
| Usefulness of Liver Uptake Rate Constant in 99mTc-GSA Scintigraphy for the Risk Stratification of Patients Undergoing Hepatectomy: A New Method for Calculation. | Visc Med | 2022 | 36589249 | PubTator, text mining | PubMed |
| The role of bile acid metabolism in the occurrence and development of NAFLD. | Front Mol Biosci | 2022 | 36589245 | PubTator, text mining | PubMed |
| ADAR1 Inhibits HBV DNA Replication via Regulating miR-122-5p in Palmitic Acid Treated HepG2.2.15 Cells. | Diabetes Metab Syndr Obes | 2022 | 36582505 | PubTator, text mining | PubMed |
| Specific Binding and Endocytosis of Liposomes to HEK293T Cells via Myrisoylated Pre-S1 Peptide Bound to Sodium Taurocholate Cotransporting Polypeptide. | Vaccines (Basel) | 2022 | 36560460 | PubTator, text mining | PubMed |
| Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities. | Pharmaceutics | 2022 | 36559237 | PubTator, text mining | PubMed |
| Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. | Int J Mol Sci | 2022 | 36555623 | PubTator, text mining | PubMed |
| Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical Trial. | Int J Mol Sci | 2022 | 36555566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=30